Medical Innovation Exchange

AbbVie coughs up nearly $50M for Cugene's autoimmune med in a bid to shore up life post-Humira


Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.